{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:12:58Z","timestamp":1763748778773,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.vaccine.2022.10.090","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T16:13:09Z","timestamp":1668269589000},"page":"7709-7713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation"],"prefix":"10.1016","volume":"40","author":[{"given":"Elizabeth Benedict","family":"Kpozehouen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandini Raina","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.10.090_b0005","unstructured":"Cardiovascular diseases (CVDs [Internet]; 2020 [cited 6 August 2021]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"10.1016\/j.vaccine.2022.10.090_b0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza Vaccination after Myocardial Infarction: A Randomised, Double-Blind, Placebo-Controlled, Multicenter Trial","author":"Fr\u00f8bert","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.090_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/joim.12875","article-title":"Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia","volume":"285","author":"Feldman","year":"2019","journal-title":"J Int Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.090_b0020","doi-asserted-by":"crossref","first-page":"e0181565","DOI":"10.1371\/journal.pone.0181565","article-title":"A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events","volume":"12","author":"Erskine","year":"2017","journal-title":"PLoS ONE"},{"issue":"15","key":"10.1016\/j.vaccine.2022.10.090_b0025","doi-asserted-by":"crossref","first-page":"e019671","DOI":"10.1161\/JAHA.120.019671","article-title":"Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement","volume":"10","author":"Bhugra","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"32","key":"10.1016\/j.vaccine.2022.10.090_b0030","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1016\/j.vaccine.2019.06.079","article-title":"Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia","volume":"37","author":"Briggs","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.10.090_b0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/21645515.2019.1682844","article-title":"Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice","volume":"16","author":"Frank","year":"2020","journal-title":"Human Vaccines Immunotherapeut"},{"key":"10.1016\/j.vaccine.2022.10.090_b0040","article-title":"The Role of Health Information Technology in Pneumococcal Vaccination Uptake Among Adults with Heart Disease","author":"Kesiena","year":"2021","journal-title":"Telemed J E Health"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.090_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.10.031","article-title":"Uptake of Influenza Vaccination and Missed Opportunities Among Adults with High-Risk Conditions, United States, 2013","volume":"129","author":"Lu","year":"2016","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.090_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hrtlng.2019.12.003","article-title":"Factors influencing the uptake of influenza vaccination in African American patients with heart failure: Findings from a large urban public hospital","volume":"49","author":"Olanipekun","year":"2020","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.090_b0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S0950268807008436","article-title":"Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999\u20132005","volume":"136","author":"Pebody","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2022.10.090_b0060","unstructured":"HealthStats NSW: Circulatory disease hospitalisations [Internet]; 2020 [cited 4 August 2021]. Available from: http:\/\/www.healthstats.nsw.gov.au\/Indicator\/cvd_projhos\/cvd_hos_lhn_trend."},{"key":"10.1016\/j.vaccine.2022.10.090_b0065","unstructured":"2016 Census QuickStats: Blacktown LGA [Internet]; 2020 [cited 17 August 2021]. Available from: https:\/\/quickstats.censusdata.abs.gov.au\/census_services\/getproduct\/census\/2016\/quickstat\/LGA10750?opendocument."},{"issue":"20","key":"10.1016\/j.vaccine.2022.10.090_b0070","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2020.03.036","article-title":"Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program","volume":"38","author":"Lin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.090_b0075","unstructured":"Australian Immunisation Handbook, Zoster (herpes zoster) [Internet]. 2020 [cited 12 June 2021]. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccine-preventable-diseases\/zoster-herpes-zoster."},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.090_b0080","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/cid\/ciz731","article-title":"Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians","volume":"70","author":"Meder","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.10.090_b0085","unstructured":"Australian Immunisation Handbook: Information about pneumococcal disease, vaccines and recommendations for vaccination from the Australian Immunisation Handbook [Internet]; 2020 [cited 23 June 2021]. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccine-preventable-diseases\/pneumococcal-disease."},{"key":"10.1016\/j.vaccine.2022.10.090_b0090","unstructured":"National Immunisation Strategy for Australia 2019 to 2024 [Internet]. 2019 [cited 16 July 2021]. Available from: https:\/\/www.health.gov.au\/news\/national-immunisation-strategy-for-australia-2019-to-2024."},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.090_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.18773\/austprescr.2020.001","article-title":"Herpes zoster vaccination in Australia: what\u2019s available and who benefits?","volume":"43","author":"Jayasinghe","year":"2020","journal-title":"Australian prescriber"},{"key":"10.1016\/j.vaccine.2022.10.090_b0100","unstructured":"Australian Institute of Health and Welfare. Trends in cardiovascular deaths; 2017."},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.090_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2019.01.025","article-title":"Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States","volume":"74","author":"Ishigami","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.090_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.ajkd.2009.04.005","article-title":"CKD and risk of hospitalisation and death with pneumonia","volume":"54","author":"James","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.090_b0115","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","article-title":"Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups","volume":"16","author":"Boey","year":"2020","journal-title":"Human Vaccines Immunotherapeut"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.090_b0120","first-page":"1","article-title":"Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Public Health"},{"issue":"46","key":"10.1016\/j.vaccine.2022.10.090_b0125","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u2265 65 years: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.10.090_b0130","unstructured":"Migration, Australiam Statistics on Australia's international migration, internal migration (interstate and intrastate), and the population by country of birth [Internet]. 2020 [cited 2 July 2021]. Available from: https:\/\/www.abs.gov.au\/statistics\/people\/population\/migration-australia\/latest-release."},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.090_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz007","article-title":"Infectious diseases at different stages of migration: an expert review","volume":"26","author":"Greenaway","year":"2019","journal-title":"J Travel Med"},{"issue":"44","key":"10.1016\/j.vaccine.2022.10.090_b0140","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1016\/j.vaccine.2019.09.025","article-title":"Barriers and facilitators of immunisation in refugees and migrants in Australia: an east-African case study","volume":"37","author":"Abdi","year":"2019","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2022.10.090_b0145","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1016\/j.vaccine.2020.09.054","article-title":"Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006\u20132018","volume":"38","author":"Charania","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.090_b0150","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay131","article-title":"Reducing infectious disease inequities among migrants","volume":"26","author":"Heywood","year":"2019","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.090_b0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1753-6405.12602","article-title":"Improving access to immunisation for migrants and refugees: recommendations from a stakeholder workshop","volume":"41","author":"Kpozehouen","year":"2017","journal-title":"Aust N Z J Public Health"},{"issue":"41","key":"10.1016\/j.vaccine.2022.10.090_b0160","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1016\/j.vaccine.2020.07.071","article-title":"Evaluating the health literacy demand and cultural appropriateness of online immunisation information available to refugee and migrant communities in Australia","volume":"38","author":"Abdi","year":"2020","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2022.10.090_b0165","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.vaccine.2021.04.062","article-title":"Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake","volume":"39","author":"Nicholls","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.090_b0170","unstructured":"Gavin Coote. Blacktown in western Sydney leads nation in vaccine uptake [Broadcast]. 2021 [updated 13 September 2021. ABC Media]. Available from: https:\/\/www.abc.net.au\/radio\/programs\/pm\/blacktown-in-western-sydney-leads-nation-in-vaccine-uptake\/13539922."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:33Z","timestamp":1759404153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22013779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0264410X22013779"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}